March 
13th
 at 
6:00pm
BioVenture eLab/IndieBio
March 
13
 at 
6:00pm

BioVenture eLab introduces IndieBio New York

RSVPs Closed
Text goes here
X

Clear your calendar - It's going down! Splash Blocks kicks off on April 21st, and you're invited to take part in the festivities. Splash HQ (122 W 26th St) is our meeting spot for a night of fun and excitement. Come one, come all, bring a guest, and hang loose. This is going to be epic!

Text Block #1

Starting your own business and picking the right niche in no time

Come meet the IndieBio team and learn about the inaugural IndieBio New York cohort of startups! IndieBio, the biotech accelerator behind companies such as Geltor and Jungla, has opened a location in New York City. 

 

In this panel conversation, the IndieBio New York team will discuss their companies, their program, and the future of biotech. What support does a startup need to succeed, and how will the New York biotech landscape change in the next 5-10 years? Bring your questions and learn more during our discussion.

 

The panel includes: 

Jahan Ali, PhD, Director, BioVenture eLab, Weill Cornell Medicine. Dr. Ali is the Director of Bioventure eLab at Weill Cornell Medical Center. Formerly, she founded and led Octane Ventures, a venture catalyst firm that works with nonprofits, universities and small biotech/health-tech companies on strategic advice, licensing and operational assistance. Dr. Ali was also a Director of Business Development at International AIDS Vaccine Initiative, where she worked with vaccine and antibody development teams. Dr. Ali brings a unique perspective to the biotech space, gained from being on multiple sides of early stage technology in technology commercialization at Mount Sinai School of Medicine and Hospital for Special Surgery and led the healthcare investments for the Partnership Fund, an investment fund founded by Henry Kravis. She has mentored numerous early stage companies, through ELabNYC and Springboard Enterprises; and is adept is building relationships with multiple stakeholders.

 

Stephen Chambers, Partner, IndieBio. Steve gained entrepreneurial experience as a founding Scientist at Vertex Pharmaceuticals and co-Founder of Abpro Therapeutics. He previously guided early-stage startups to success as co-founder of Bio-Start, the United Kingdom's first life sciences accelerator. 

 

Sam Lee, Program Director, IndieBio. Sam applied his chemistry training first at DuPont before transitioning into life sciences. He is the former Business Development and Senior Director of Research at NPS Pharmaceuticals, and former Head of R&D Innovation at Dr. Reddy's Laboratories. 

 

Julie Wolf, Communications Director, IndieBio. Julie has science communications experience from her previous work with the American Society for Microbiology and from teaching at the Brooklyn community biolab, Genspace. She was also co-Founder of Brooklyn Bio, Inc.

Inventors and innovators wanted!

Do you have an idea for a medical device but aren’t sure what to do next or how to produce it? Join us in the brand-new BioVenture eLab for an exciting evening to discuss medical device innovation as we begin a new initiative to gather like-minded individuals interested in the field.

 

All backgrounds are encouraged to attend: i.e., surgeons, clinicians, researchers, business, graduate students, engineers etc.

Come meet the IndieBio team and learn about the inaugural IndieBio New York cohort of startups! IndieBio, the biotech accelerator behind companies such as Geltor and Jungla, has opened a location in New York City. 

 

In this panel conversation, the IndieBio New York team will discuss their companies, their program, and the future of biotech. What support does a startup need to succeed, and how will the New York biotech landscape change in the next 5-10 years? Bring your questions and learn more during our discussion.

 

The panel includes: 

Jahan Ali, PhD, Director, BioVenture eLab, Weill Cornell Medicine. Dr. Ali is the Director of Bioventure eLab at Weill Cornell Medical Center. Formerly, she founded and led Octane Ventures, a venture catalyst firm that works with nonprofits, universities and small biotech/health-tech companies on strategic advice, licensing and operational assistance. Dr. Ali was also a Director of Business Development at International AIDS Vaccine Initiative, where she worked with vaccine and antibody development teams. Dr. Ali brings a unique perspective to the biotech space, gained from being on multiple sides of early stage technology in technology commercialization at Mount Sinai School of Medicine and Hospital for Special Surgery and led the healthcare investments for the Partnership Fund, an investment fund founded by Henry Kravis. She has mentored numerous early stage companies, through ELabNYC and Springboard Enterprises; and is adept is building relationships with multiple stakeholders.

 

Stephen Chambers, Partner, IndieBio. Steve gained entrepreneurial experience as a founding Scientist at Vertex Pharmaceuticals and co-Founder of Abpro Therapeutics. He previously guided early-stage startups to success as co-founder of Bio-Start, the United Kingdom's first life sciences accelerator. 

 

Sam Lee, Program Director, IndieBio. Sam applied his chemistry training first at DuPont before transitioning into life sciences. He is the former Business Development and Senior Director of Research at NPS Pharmaceuticals, and former Head of R&D Innovation at Dr. Reddy's Laboratories. 

 

Julie Wolf, Communications Director, IndieBio. Julie has science communications experience from her previous work with the American Society for Microbiology and from teaching at the Brooklyn community biolab, Genspace. She was also co-Founder of Brooklyn Bio, Inc.

Text Block #11

Starting your own business and picking the right niche in no time

Come meet the IndieBio team and learn about the inaugural IndieBio New York cohort of startups! IndieBio, the biotech accelerator behind companies such as Geltor and Jungla, has opened a location in New York City. 

 

In this panel conversation, the IndieBio New York team will discuss their companies, their program, and the future of biotech. What support does a startup need to succeed, and how will the New York biotech landscape change in the next 5-10 years? Bring your questions and learn more during our discussion.

 

The panel includes: 

Jahan Ali, PhD, Director, BioVenture eLab, Weill Cornell Medicine. Dr. Ali is the Director of Bioventure eLab at Weill Cornell Medical Center. Formerly, she founded and led Octane Ventures, a venture catalyst firm that works with nonprofits, universities and small biotech/health-tech companies on strategic advice, licensing and operational assistance. Dr. Ali was also a Director of Business Development at International AIDS Vaccine Initiative, where she worked with vaccine and antibody development teams. Dr. Ali brings a unique perspective to the biotech space, gained from being on multiple sides of early stage technology in technology commercialization at Mount Sinai School of Medicine and Hospital for Special Surgery and led the healthcare investments for the Partnership Fund, an investment fund founded by Henry Kravis. She has mentored numerous early stage companies, through ELabNYC and Springboard Enterprises; and is adept is building relationships with multiple stakeholders.

 

Stephen Chambers, Partner, IndieBio. Steve gained entrepreneurial experience as a founding Scientist at Vertex Pharmaceuticals and co-Founder of Abpro Therapeutics. He previously guided early-stage startups to success as co-founder of Bio-Start, the United Kingdom's first life sciences accelerator. 

 

Sam Lee, Program Director, IndieBio. Sam applied his chemistry training first at DuPont before transitioning into life sciences. He is the former Business Development and Senior Director of Research at NPS Pharmaceuticals, and former Head of R&D Innovation at Dr. Reddy's Laboratories. 

 

Julie Wolf, Communications Director, IndieBio. Julie has science communications experience from her previous work with the American Society for Microbiology and from teaching at the Brooklyn community biolab, Genspace. She was also co-Founder of Brooklyn Bio, Inc.

#BioVentureMedicalDeviceInnovationEvent
Share with Friends
Facebook
Twitter
LinkedIn
Link
Powered by
CONTACT THE ORGANIZER
Google   Outlook   iCal   Yahoo
Sorry, RSVPs have closed.